When may interpreters participate in research or data collection, and what protections apply?

• A. Only with informed consent and IRB approval; protect privacy, de-identify data, minimize PHI exposure, and follow institutional policies.
• B. Whenever they want; no protections needed.
• C. Only if patient agrees but without IRB.
• D. Only in non-clinical settings.

Answer: (A)

When interpreters participate in research or data collection, formal protections for people involved in research must apply. This means obtaining informed consent when participants are identifiable or when required by the study, securing IRB (or equivalent) review and oversight of the project, and implementing safeguards to protect privacy and confidentiality. Data should be handled in ways that minimize risk, including de-identifying information and limiting exposure of any personal health information, all while following applicable institutional policies and regulatory requirements.

This approach is necessary because it respects participants’ autonomy, reduces potential harm, and ensures the research is conducted ethically and responsibly. IRB review helps ensure the study design poses minimal risk and includes appropriate safeguards, while informed consent ensures participants understand what they are agreeing to and can choose to participate freely. De-identification and privacy protections lower the chance that sensitive information is exposed, protecting individuals’ confidentiality and complying with laws and standards.

Options that suggest protections aren’t needed, that anyone can participate without oversight, or that protections apply only in non-clinical settings don’t align with how research involving people is governed.